To examine the long-term effect of interferon (IFN) therapy in patients with chronic hepatitis B virus (HBV) infection, particularly on survival and hepatocellular carcinoma (HCC) prevention, 101 male patients with chronic hepatitis B in a randomized controlled trial were followed up for 1.1 to 11.5
Partial splenic embolization facilitates completion of interferon therapy in patients with chronic HCV infection and hypersplenism
β Scribed by Masaki Kato; Naoya Shimohashi; Jiro Ouchi; Kisaku Yoshida; Yuichi Tanabe; Kenji Takenaka; Makoto Nakamuta
- Publisher
- Springer Japan
- Year
- 2005
- Tongue
- English
- Weight
- 138 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Natural killer (NK) cells are implicated in the regulation of a protective immune response in patients chronically infected with hepatitis C virus (HCV), but effects of interferonβΞ±/ribavirin therapy on NK cell subsets and the consequences of viral clearance during therapy remain unclea
Whether sustained biochemical response and absence of serum HCV RNA in the 6-12 months following suspension of interferon-β£ (IFN-β£) therapy reflect definitive viral clearance in patients with chronic hepatitis C virus (HCV) infection is controversial. To obtain more information on this topic, HCV RN
## Abstract To determine the virological factors associated with a favorable longβterm response to interferonβΞ± (IFN) therapy in chronic hepatitis C virus (HCV) infection, 61 Japanese patients with chronic HCV infection were treated with IFN for 24 weeks (780 million units in total) and followed fo